Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Evonetix Ltd.

Headquarters: Little Chesterford, United Kingdom
Year Founded: 2016
Status: Private

BioCentury | Feb 7, 2023
Deals

Feb. 7 Quick Takes: Garuda advancing stem cell program with $62M series B

Plus: Evonetix tops off series B and updates from Aldeyra, Neuron23, Slingshot and more
BioCentury | Jun 14, 2022
Management Tracks

McCracken named CEO at Evonetix

Plus Pirzkall becomes CMO at Asher, and updates from Domain, Syndax, 
BioCentury | Apr 26, 2022
Management Tracks

Nektar to cut 70% of staff; Nuyten, Northcott to depart

Plus Carisma names co-founder Klichinsky as CSO and updates from Caravella, Reeve Foundation, Evonetix and more
BioCentury | Sep 13, 2019
Tools & Techniques

Enzymes aim to beat chemistry by creating longer, speedier, cleaner DNA strands

Companies are pushing the limits of DNA synthesis by turning from chemistry to enzymes
BioCentury | Feb 2, 2018
Financial News

Evonetix raises $12.3M series A

Items per page:
1 - 5 of 5